JCM
TMO icon

Jacobi Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Jacobi Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
4,663
+87
+2% +$41.8K 0.11% 163
2026
Q1 		$2.25M Sell
4,576
-16
-0.3% -$8.68K 0.13% 152
2025
Q4 		$2.66M Sell
4,592
-42
-0.9% -$23.8K 0.15% 126
2025
Q3 		$2.25M Buy
4,634
+114
+3% +$53.1K 0.14% 149
2025
Q2 		$1.83M Buy
4,520
+472
+12% +$197K 0.12% 167
2025
Q1 		$2.01M Sell
4,048
-32
-0.8% -$17.3K 0.15% 143
2024
Q4 		$2.12M Buy
4,080
+57
+1% +$31.3K 0.16% 133
2024
Q3 		$2.49M Buy
4,023
+85
+2% +$50.3K 0.19% 109
2024
Q2 		$2.18M Buy
3,938
+13
+0.3% +$7.45K 0.19% 103
2024
Q1 		$2.28M Buy
3,925
+74
+2% +$41.5K 0.21% 90
2023
Q4 		$2.04M Sell
3,851
-11
-0.3% -$5.32K 0.21% 95
2023
Q3 		$1.95M Buy
3,862
+178
+5% +$94.9K 0.22% 91
2023
Q2 		$1.92M Sell
3,684
-364
-9% -$196K 0.22% 98
2023
Q1 		$2.33M Buy
4,048
+103
+3% +$58.1K 0.28% 75
2022
Q4 		$2.17M Buy
3,945
+119
+3% +$63.1K 0.27% 78
2022
Q3 		$1.94M Buy
3,826
+16
+0.4% +$8.95K 0.27% 79
2022
Q2 		$2.07M Buy
3,810
+21
+0.6% +$11.6K 0.28% 73
2022
Q1 		$2.24M Buy
3,789
+174
+5% +$100K 0.27% 71
2021
Q4 		$2.41M Buy
3,615
+166
+5% +$104K 0.29% 66
2021
Q3 		$1.97M Buy
3,449
+33
+1% +$18.1K 0.25% 75
2021
Q2 		$1.72M Buy
3,416
+303
+10% +$143K 0.23% 83
2021
Q1 		$1.42M Buy
3,113
+209
+7% +$99.8K 0.21% 94
2020
Q4 		$1.38M Buy
2,904
+18
+0.6% +$8.44K 0.22% 90
2020
Q3 		$1.29M Buy
2,886
+438
+18% +$181K 0.23% 84
2020
Q2 		$887K Buy
2,448
+11
+0.5% +$3.69K 0.17% 108
2020
Q1 		$691K Sell
2,437
-442
-15% -$139K 0.15% 117
2019
Q4 		$935K Buy
2,879
+45
+2% +$13.6K 0.17% 114
2019
Q3 		$826K Buy
2,834
+19
+0.7% +$5.44K 0.16% 117
2019
Q2 		$827K Buy
2,815
+199
+8% +$54.8K 0.17% 118
2019
Q1 		$716K Buy
2,616
+16
+0.6% +$3.98K 0.18% 83
2018
Q4 		$582K Buy
2,600
+1,540
+145% +$361K 0.16% 100
2018
Q3 		$259K Hold
1,060
– – 0.07% 175
2018
Q2 		$219K Buy
1,060
+152
+17% +$32.3K 0.06% 192
2018
Q1 		$184K Buy
908
+284
+46% +$59.6K 0.06% 195
2017
Q4 		$126K Buy
624
+187
+43% +$35.8K 0.04% 226
2017
Q3 		$84K Buy
437
+1
+0.2% +$181 0.03% 266
2017
Q2 		$78K Hold
436
– – 0.03% 247
2017
Q1 		$67K Buy
436
+124
+40% +$19K 0.03% 205
2016
Q4 		$46K Sell
312
-124
-28% -$18.3K 0.03% 224
2016
Q3 		$69K Hold
436
– – 0.03% 197
2016
Q2 		$65K Buy
+436
New +$64.3K 0.03% 200

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Jacobi Capital Management's TMO Position: Q2 2026 in Review

Jacobi Capital Management increased its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, buying an estimated $41.8K and bringing the position to 4,663 shares worth $2.34M. The position accounts for 0.11% of the portfolio, ranked #163.

Jacobi Capital Management first reported a position in TMO in Q2 2016 and has held it in 41 quarters since. The position peaked at $2.66M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Jacobi Capital Management held 4,663 shares of Thermo Fisher Scientific worth $2.34M as of Q2 2026.
  • Jacobi Capital Management bought 87 Thermo Fisher Scientific shares in Q2 2026, an estimated $41.8K.
  • Thermo Fisher Scientific made up 0.11% of Jacobi Capital Management's portfolio in Q2 2026, its #163 holding.
  • Jacobi Capital Management first reported a position in Thermo Fisher Scientific in Q2 2016 and has held it in 41 quarters since.
  • Jacobi Capital Management's Thermo Fisher Scientific position peaked at $2.66M in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.